CRISPR Therapeutics, Merck Lag
This is a news story, published by Yahoo Finance, that relates primarily to Casgevy news.
Casgevy news
For more Casgevy news, you can click here:
more Casgevy newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
CRISPR Therapeutics. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest innovative medical therapies news, Vertex Pharmaceuticals news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
patient investorsThe Motley Fool
•Health
Health
2 Beaten-Down Stocks to Buy on the Dip
79% Informative
CRISPR Therapeutics' shares are down by 41% over the trailing-12-month period.
Merck 's best-selling medicine is Keytruda 's sales were $29.5 billion , up 18% year over year .
The company earned approval for Casgevy , which treats a pair of rare blood diseases, in late 2023 .
Merck is a solid dividend stock.
Despite dropping by more than 20% in the past year , the stock is an excellent pick for long-term investors.
Merck 's issues are real, but it's encountered similar ones before in its long and storied history and has always come out on top.
VR Score
78
Informative language
77
Neutral language
18
Article tone
semi-formal
Language
English
Language complexity
48
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
7
Source diversity
2
Affiliate links
no affiliate links
Small business owner?